Cigna (NYSE:CI) Group, and UnitedHealth Group Inc (NYSE:UNH) were down around 1% after the Federal Trade Commission (FTC) accused their pharmacy benefit manager units of imposing ...
It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...
The U.S. Federal Trade Commission (FTC) has slammed pharmacy benefit managers (PBMs) owned by UnitedHealth ($UNH), CVS Health ($CVS) and Cigna ...
The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...
Newsweek on MSN14d
UnitedHealth Charged Cancer Patients 5000%, Bombshell FTC Report ClaimsThe FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...
Cigna Group CEO David Cordani said the company will make investments this year to improve patient and provider experiences ...
The report is the latest indictment of America’s broken healthcare system.
The FTC released a 60-page report Tuesday targeting the biggest three pharmacy benefit managers, claiming the companies hiked ...
News Nation on MSN12d
UnitedHealth marked up lifesaving drugs as much as 1,000%: FTCBetween 2017 and 2022, UnitedHealth Group’s Optum, Cigna’s Express Scripts and CVS Health’s CVS Caremark marked up their ...
The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...
TD Cowen analyst Ryan Langston maintained a Buy rating on Cigna (CI – Research Report) today and set a price target of $391.00. The company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback